The following is a list a of deals covered in detail by M&A Navigator this week:- FRENCH SODIAAL PLANS BID FOR TROUBLED ENTREMONTFrench dairy group Sodiaal plans to make alone an offer to acquire struggling sector player Entremont.Status: Bidding- SONAE SIERRA TO UNLOAD 41% OF GERMAN ALEXA MALL FOR EUR142MPortuguese shopping centre operator Sonae Sierra [...]
The following is a list a of deals covered in detail by M&A Navigator this week:- ALFA, TELENOR CLOSER TO MERGING VIMPELCOM, KYIVSTARThe board of Russian telecommunications company Vimpelcom (RTD:VIMP) has recommended that shareholders exchange their stock for Vimplecom Ltd (NYSE:VIP) depositary shares, following which Vimpelcom Ltd will buy all the shares of Ukrainian mobile [...]
The following is a list a of deals covered in detail by M&A Navigator this week:KAZAKH FUND TO SELL BTA BANK STAKE TO RUSSIA’S SBERBANK Kazakhstan’s state-owned fund Samruk-Kazyna will start talks on the disposal of some of its holding in BTA Bank (KAS:BTAS) to Russian bank Sberbank (RTC:SBER) in the second quarter of 2010.Status: [...]
The following is a list of deals covered in detail by M&A Navigator this week:- SWEDISH BURE EQUITY, ALTOR SELL 25% OF CARNEGIE INVESTMENT BANKSwedish investment company Bure Equity (STO:BURE), together with its partner Altor Fund III, has wrapped up the sale of a 25% stake in Carnegie Investment Bank (CIB) to some 250 CIB [...]
2009 DEC 11 – (NewsRx.com) NOD Pharmaceuticals Inc. announced the US Patent & Trademark Office (PTO) has allowed the patent application for its nano-particle oral delivery or NOD technology (see also NOD Pharmaceuticals, Inc.).NOD technology is a highly efficient approach to incorporate peptides or proteins into bio-adhesive nano-particles to enable oral delivery of drugs [...]
2009 DEC 7 – (NewsRx.com) Shanghai Biolaxy announced the Chinese State Food & Drug Administration (SFDA) has approved the investigational new drug application (IND) for its oral insulin project (Nodlin), an innovative insulin formulation to treat diabetes. This IND approval allows Biolaxy to initiate its first phase I clinical study (see also Shanghai Biolaxy).Diabetes [...]
SHANGHAI, Nov. 24 /PRNewswire-Asia/ Shanghai Biolaxy announced theChinese State Food & Drug Administration (SFDA) has approved theinvestigational new drug application (IND) for its oral insulin project(Nodlin), an innovative insulin formulation to treat diabetes. This INDapproval allows Biolaxy to initiate its first phase I clinical study. Diabetes is a disorder characteristic of [...]
SHANGHAI, Nov. 24 /PRNewswire-Asia/ NOD Pharmaceuticals Inc. announcedthe US Patent & Trademark Office (PTO) has allowed the patent application forits nano-particle oral delivery or NOD technology. NOD technology is a highly efficient approach to incorporate peptides orproteins into bio-adhesive nano-particles to enable oral delivery of drugsotherwise administered as injections. NOD technology [...]
Dublin – Research and Markets has announced the addition of the "Radiopharmaceuticals – A US and European Market Analysis" report to their offering.The market for radiopharmaceuticals continues to gain momentum with heightened interest in therapeutic efficiency, acceptance and utilization of nuclear medicine equipment, as well as development of newer diagnostic and therapeutic agents. Besides oncology [...]
DUBLIN(BUSINESS WIRE) Research and Markets has announced the addition of the "Radiopharmaceuticals – A US and European Market Analysis" report to their offering. The market for radiopharmaceuticals [...]
